Notify me when Michael B. Chancellor files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LIPO | Lipella Pharmaceuticals Inc. | Common Stock, par value $0.0001 per share | 4.8% | $512K | $2.44 | 210K | +0% | Michael B. Chancellor | 07 Apr 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|